Cyclopharm Ltd operates in the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cyclopharm Ltd with three other
companies in this sector in AUSTRALIA :
Genetic Signatures Ltd
(2020
sales of 14.09 million Australian Dollars [US$10.21 million]
),
Mach7 Technologies Ltd
(18.86 million Australian Dollars [US$13.67 million]
of which 58%
was Software licenses), and
Nova Eye Medical Ltd
(12.82 million Australian Dollars [US$9.29 million]
of which 90%
was iTrack).
Sales Analysis.
During the second
quarter of 2021, sales at Cyclopharm Ltd totalled
A$8.34 million.
This is
an increase of 44.5%
from the A$5.77 million in sales at the company during the second quarter of 2020.
Cyclopharm Ltd reported sales of A$14.68 million (US$10.64 million)
for the
year ending
December of 2020.
This
represents
an
increase of 4.1%
versus 2019, when the company's sales were A$14.10 million.
This was the third consecutive year of growth at Cyclopharm Ltd.